Key Points
- Astera Labs CEO Jitendra Mohan sold 2,967 shares on April 15 at $174.60 for $518,038.20 under a pre-arranged Rule 10b5-1 trading plan, leaving him with 4,405,015 shares (about $769.1M) — a 0.07% ownership decrease.
- Mohan executed much larger sales earlier this year (Feb 17, Mar 17 and Apr 10), bringing his total insider sales since February to roughly $51.5 million, signaling a pattern of substantial dispositions.
- Separately, Astera Labs reported a strong quarter with $0.58 EPS vs. $0.51 expected and revenue of $270.58M (up 91.8% YoY), and set Q1 2026 EPS guidance of $0.530–$0.540 amid a consensus "Moderate Buy" and average target near $199.44.
Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) CEO Jitendra Mohan sold 2,967 shares of Astera Labs stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $174.60, for a total transaction of $518,038.20. Following the sale, the chief executive officer owned 4,405,015 shares of the company's stock, valued at approximately $769,115,619. The trade was a 0.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jitendra Mohan also recently made the following trade(s):
- On Friday, April 10th, Jitendra Mohan sold 123,750 shares of Astera Labs stock. The shares were sold at an average price of $149.68, for a total value of $18,522,900.00.
- On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00.
- On Tuesday, February 17th, Jitendra Mohan sold 94,971 shares of Astera Labs stock. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51.
Astera Labs Trading Down 0.7%
Astera Labs stock opened at $170.81 on Friday. Astera Labs, Inc. has a 12 month low of $52.56 and a 12 month high of $262.90. The stock's 50 day simple moving average is $129.75 and its two-hundred day simple moving average is $154.53. The firm has a market cap of $29.25 billion, a PE ratio of 140.01, a P/E/G ratio of 3.39 and a beta of 1.78.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts' consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business had revenue of $270.58 million for the quarter, compared to analysts' expectations of $249.46 million. During the same quarter last year, the company earned $0.37 EPS. The business's revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on ALAB shares. Citigroup began coverage on shares of Astera Labs in a report on Thursday, April 2nd. They issued a "buy" rating and a $200.00 price objective for the company. Barclays set a $165.00 target price on shares of Astera Labs in a research note on Thursday, January 15th. Royal Bank Of Canada began coverage on Astera Labs in a research note on Wednesday, January 14th. They issued an "outperform" rating and a $225.00 price target for the company. Loop Capital began coverage on Astera Labs in a report on Thursday, March 5th. They issued a "buy" rating and a $250.00 price target for the company. Finally, Weiss Ratings downgraded Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Monday, February 23rd. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $199.44.
View Our Latest Report on Astera Labs
Hedge Funds Weigh In On Astera Labs
Large investors have recently added to or reduced their stakes in the stock. Assetmark Inc. lifted its holdings in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company's stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Reflection Asset Management purchased a new stake in shares of Astera Labs during the fourth quarter worth about $25,000. Smartleaf Asset Management LLC raised its position in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock worth $32,000 after purchasing an additional 152 shares during the last quarter. Hilltop National Bank raised its position in shares of Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company's stock worth $33,000 after purchasing an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC purchased a new position in Astera Labs in the 4th quarter valued at about $33,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.
About Astera Labs
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
